Day: December 29, 2022
TinyML AI Combined with LoRaWAN to Enable Ultralow Power, Long-Range Transmission and High-Performance AI for Indoor and Outdoor Utilization
TAINAN, Taiwan and SHENZHEN, China , Dec. 29, 2022 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, and Seeed Studio, the IoT hardware partner providing services that empower developers to implement their projects and products for digital transformation, today announced the joint showcase of the SenseCAP A1101 LoRaWAN Vision AI Sensor, embedded with Himax WiseEye™ smart image sensing solution (“WiseEye”), at the upcoming CES 2023 from January 5 – 8, 2023 in Las Vegas, Nevada.
Seeed Studio, with its tinyML Edge AI platform enabling expertise, has created...
RECHARGE RECEIVES DATASET AND REPORTS FROM AIRBORNE MAG SURVEY AT GEORGIA LAKE LITHIUM PROJECT TO DEMONSTRATE ‘STRUCTURAL CONTINUITY’ FROM NEIGHBOUR ROCK TECH AWAITING INTERPRETATION
Written by Customer Service on . Posted in Public Companies.
Vancouver, BC, Dec. 29, 2022 (GLOBE NEWSWIRE) — Recharge Resources Ltd. (“Recharge” or the “Company”) (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) is pleased to announce that Prospectair Geosurveys has finalized processing the high-resolution heliborne magnetic survey data collected from the company’s 100% owned Georgia Lake North and West Lithium Properties in Ontario, Canada (the “Property”).
The Property is immediately contiguous to Rock Tech Lithium Inc’s (RCK–V) (“Rock Tech”) Georgia Lake Lithium Property and located approximately 160 km northeast of Thunder Bay, Ontario, within the Thunder Bay Mining Division.
Recharge will be reviewing the data over the next month to implement a spring field program consisting of geological mapping and prospecting over target areas once conditions are favourable.
CEO, David Greenway, stated,...
Standard Lithium Receives Notice of Allowance for Final U.S. Patent Covering DLE Process for Recovering Lithium From Brines
Written by Customer Service on . Posted in Public Companies.
Successful Completion of USPTO Review Process for Company’s Lithium Extraction Patents
VANCOUVER, British Columbia, Dec. 29, 2022 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, is pleased to announce that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for Standard Lithium’s third U.S. patent application serial no. 16/895,783 titled “Process for Recovering Lithium from Brines”, This third U.S. patent application is in addition to Standard Lithium’s other two U.S. patent applications for which Notices of Allowance have been earlier issued by the USPTO (U.S. patent applications serial no.16/410,523 and serial no. 16/224/463, both also titled “Process for Recovering Lithium...
Junshi Biosciences Announces NEJM Publication of Results of Phase 3 Study of VV116 Versus PAXLOVID for Adults at High Risk for Progression to Severe COVID-19
Written by Customer Service on . Posted in Public Companies.
SHANGHAI, China, Dec. 29, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announces the online publication in New England Journal (NEJM) of the Phase 3 trial (NCT05341609) comparing the efficacy and safety of VV116 (JT001) and nirmatrelvir/ritonavir (“PAXLOVID”) in the treatment of symptomatic patients with mild to moderate COVID-19 who are at high risk for progression to severe COVID-19 including death. It is the first time that NEJM published the clinical trial results of China-developed anti-SARS-CoV-2 drug.
The study, led by Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, is the first “head-to-head” phase...